If you think that you may have the COVID-19 virus, you can use this self-assessment tool.
If you have any questions about the impact of COVID-19 as a breast cancer patient, email us at email@example.com
Cancer and COVID-19
Cancer Added to List of High-Risk Conditions
Individuals who are older, have underlying medical condition(s) or who are immuno-compromised were identified as being at a higher risk of having severe complications if they were to contract COVID-19, when the virus was first announced. A handful of studies went on to show that individuals with cancer were at high-risk of COVID-19 complications as well. Based on such data, the CDC officially added cancer to their list of conditions that can lead to an increased risk of severe illness on July 17th. At this time, the CDC has not made an official statement on how a history of cancer impacts one's risk.
It's important to note that past studies have shown that all cancer patients don't have the same risk level. Risk level can be impacted by the stage of cancer and type of cancer treatment as well as the type of cancer, with breast cancer patients being identified as having a lower risk of complications when compared to other types of cancers.
Latest Research on the Impact of COVID-19 on Cancer Patients
The COVID-19 & Cancer Consortium (CCC19) is a patient registry launched and crowd-sourced by cancer researchers from over 100 institutions that analyzes the impact of COVID-19 on cancer patients. Their first study, published in May, showed that patients in active treatment, who are older and who have comorbidities were at a higher risk of COVID-19 complications. Their latest findings, released near the end of July, shows that cancer patients who contract COVID-19 die at a rate 3 times higher than non-cancer COVID-19 patients. Their first findings included around 1,000 patients and showed a mortality rate of 13% while their second findings included a little over 2,000 patients and showed a mortality rate of 16%.
Making Cancer Testing and Treatment Accessible During the Pandemic
Project ACTT (Access to Cancer Testing & Treatment) is a $2,590,000 initiative developed to provide cancer patients with access to testing and treatment. The initiative will use a liquid biopsy solution that needs a simple blood draw for cancer treatment, as a way to eliminate cancer patients having to go to hospitals for surgical biopsies. Project ACTT, composed of 10 institutions, will help in getting cancer patients the treatment they need while reducing their risk of contracting COVID-19 if they were to have to go into the hospital.
COVID-19's Impact on Breast Cancer Care
In Special Report: COVID-19’s Impact on Breast Cancer Care, Breastcancer.org rounds up important information on the impact of COVID-19 on breast care care, from the risks breast cancer patients face to how to get the best care possible.
CBCN has produced the following resources on navigating COVID-19 as a breast cancer patient since the start of the pandemic: